The Public Health Fixes that Missed the Omnibus Bill

The Public Health Fixes that Missed the Omnibus Bill

In this JAMA Health Forum commentary, SHP's Michelle Mello and colleagues argue that the $1.7 trillion omnibus bill that Congress passed in December 2022 responds to several urgent public health needs, yet only narrowly addresses some of the critical determinants of pandemic preparedness.
The Capitol Building Harold Mendoza/Unsplash

As the third year of the COVID-19 emergency draws to a close, policy makers have begun to assess and apply its lessons for health policy. At the national level, the $1.7 trillion omnibus bill that Congress passed in December 2022 reflects some of what the nation has learned from the pandemic. The legislation responds to several urgent needs, yet only narrowly addresses some of the critical determinants of pandemic preparedness.

The pandemic exacerbated a set of already profound health issues: maternal and infant mortality, opioid use disorder, mental health problems, poor access to care in the rural US, and health inequities. The omnibus bill recognizes these issues with provisions that, if well implemented, could make a meaningful difference:

  • The omnibus permanently gives states the option to provide 12 months of Medicaid coverage to new mothers. It requires states to give children 12 months of continuous Medicaid and Children’s Health Insurance Program coverage even if family circumstances change. It also creates a maternal health hotline, funds maternal depression and substance use screening, and increases funding for other maternal and child health programs.

  • The legislation funds several new programs focused on mental health and substance use disorders during and outside of emergencies. Examples include peer-to-peer mental health services, optimizing responses to individuals experiencing mental health crises, and early intervention for high-risk children. It strengthens enforcement of mental health parity regulations and extends them to state and local government health plans. Several provisions will improve access to medications for opioid use disorder, especially elimination of the requirement that practitioners obtain a special Drug Enforcement Administration waiver to prescribe buprenorphine. The bill also contains sizeable appropriations for state and tribal opioid response programs.

  • To expand access to care more generally, the omnibus extends regulatory waivers relating to telehealth services through 2024. This step is particularly important for patients in rural areas and those seeking mental health services.

  • To support health equity, the omnibus includes new funding for community health workers to focus on social determinants of health, and a grant program addressing social determinants. These programs reflect recognition that socially disadvantaged communities are at the greatest risk of the worst outcomes in any public health emergency, as well as outside of emergencies.

 

Read the Full Commentary in JAMA Health Forum

 

Michelle Mello Stanford

Michelle Mello

Professor of Health Policy and Law
Mello focuses on the intersection of law, ethics, and health policy.
Profile

Read More

Wastewater plant
News

Benefits of Wastewater Surveillance for Combating Infectious Diseases

A recently released report from an expert committee of the National Academies of Sciences, Engineering, and Medicine — including Stanford Law School and Department of Health Policy professor Michelle Mello and former Rosenkranz Prize winner Ami Bhatt — focuses on how wastewater monitoring has become a critical tool in the fight against infectious diseases.
cover link Benefits of Wastewater Surveillance for Combating Infectious Diseases
Clinical trail test tubes
News

A New System to Encourage Greater Inclusion in Drug Research

A new paper by Michelle Mello and colleagues at Stanford and Yale outlines the "fair inclusion score," which ranks pharmaceutical companies on their inclusion of racial and ethnic minoritized groups, women, and the elderly in clinical trials.
cover link A New System to Encourage Greater Inclusion in Drug Research
Biden celebration at White House for passage of Inflation Reduction Act 2022
Q&As

How the Inflation Reduction Act Impacts Health Policy

Michelle Mello — a professor of heath policy and law — attended the Sept. 13 gathering at the White House to celebrate the passing of the Inflation Reduction Act 2022. She was invited for her contributions on Medicare price negotiation modeling for the landmark piece of legislation. In this Q&A, she discusses the bill's impact on health policy.
cover link How the Inflation Reduction Act Impacts Health Policy